A. Krick

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

Meihua Wang, M. Kohn, Temitope A Folaranmi, 2021, Human vaccines & immunotherapeutics.

4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years

D. Ferris, A. Saah, J. Mehlsen, 2017, Pediatrics.

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

A. Giuliano, P. van Damme, E. Moreira, 2017, Human vaccines & immunotherapeutics.